Wolbachia-infected Mosquitoes Released in Florida

The bacterium causes eggs to die, and spreading treated insects is expected to curb Aedes aegypti populations.

kerry grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, TUPINUMBAH

Kentucky-based MosquitoMate released 20,000 male Aedes aegypti this week (April 18) in a field trial in the Florida Keys, testing the insects’ abilities to tamp down the local mosquito population. These male mosquitoes were treated with the bacterium Wolbachia, which causes eggs to perish when infected males mate with uninfected females.

“We’re looking at these sterile insect techniques because our conventional mosquito control methods are costly and labor-intensive,” Andrea Leal, executive director of the Florida Keys Mosquito Control District, told the Associated Press.

Wolbachia-laced mosquitoes have been deployed in several sites around the globe, including Colombia, Brazil, and Vietnam. MosquitoMate’s insects were previously tested in California.

According to the company’s website, 40,000 mosquitoes will be released each week for 12 weeks.

Earlier this year, scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development